The Patent Finder

Sigma-Tau Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Sigma-Tau Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Sigma-Tau Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,333,894Methods for the diagnosis of hemodialysis patients and utilization of such methods to improve the administration of intravenous levocarnitine treatments to hemodialysis patients
Formerly held
Term ended
Term ended Nov 26, 2024 · USPTO record
Term endedTerm ended Nov 26, 2024USPTO record
US 7,011,977Quantification of carnitine levels in dialysis patients
Formerly held
Term ended
Term ended Oct 3, 2019 · USPTO record
Term endedTerm ended Oct 3, 2019USPTO record
US 4,839,159Topical L-carnitine composition
Term ended
Term ended no later than Jun 13, 2009 · Low confidence
Term endedTerm ended no later than Jun 13, 2009Low confidence
US 5,686,491Infant formula
Term ended
Term ended no later than Nov 11, 2017 · Low confidence
Term endedTerm ended no later than Nov 11, 2017Low confidence
US 5,958,886Carnitine-containing peptides and a method for using the same
Term ended
Term ended no later than Sep 28, 2019 · Low confidence
Term endedTerm ended no later than Sep 28, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited